Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 22°C (overcast clouds)
Topic Feed

WetAmd

Showing the latest stories and updates for this topic.
Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News

Why Did Regenxbio (RGNX) Shares Take Such a Steep Dive After Hours? Unpacking the Gene Therapy News
Regeneron's Remarkable Resurgence: Charting the Course of a Biotech Comeback

Regeneron's Remarkable Resurgence: Charting the Course of a Biotech Comeback
Dame Judi Dench's Vision Struggles: Understanding Macular Degeneration

Dame Judi Dench's Vision Struggles: Understanding Macular Degeneration
Lilly's Bold Bet: A Second Chance for a Troubled Gene Therapy in Retinal Disease

Lilly's Bold Bet: A Second Chance for a Troubled Gene Therapy in Retinal Disease
A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle

A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle
Ocular Therapeutix Soars Amid Frenzied Takeover Whispers: Is Amgen Eyeing a Biotech Gem?

Ocular Therapeutix Soars Amid Frenzied Takeover Whispers: Is Amgen Eyeing a Biotech Gem?
FDA Delivers Crushing Blow to Outlook Therapeutics: Eye Drug Approval for Wet AMD Declined

FDA Delivers Crushing Blow to Outlook Therapeutics: Eye Drug Approval for Wet AMD Declined
Load more..